Particle Sciences Implements Novel Microfluidics Reaction Technology(TM) (MRT) to Offer Bottom-up Nanoparticle Creation Solutions to Customers

Particle Sciences Implements Novel Microfluidics Reaction Technology(TM) (MRT) to Offer Bottom-up Nanoparticle Creation Solutions to Customers

Revolutionary high shear, high pressure bottom-up technology enables continuous pharmaceutical manufacturing through crystallization and chemical reactions

PR Newswire

BETHLEHEM, Pa., May 4 /PRNewswire/ -- Particle Sciences and Microfluidics extended their collaboration with the placement of the newly-announced Microfluidics Reaction Technology (MRT) system at Particle Sciences. This revolutionary technology combines a high shear, high pressure impinging jet processor with expert process development to generate unique results in bottom-up nanoparticle creation and continuous pharmaceutical manufacturing through crystallization and chemical reactions.

According to Robert Lee, Ph.D., Vice President of Pharmaceutical Development at Particle Sciences, "Particle Sciences is extremely pleased with the potential of MRT and we have successfully used it with several client-driven projects. It definitely provides a unique approach to bottom-up nanoparticle formulation, one that lends itself to being scaled and conforming to cGMP requirements."

According to Bill Kober, Vice President of Sales, Americas, at Microfluidics, "According to a recent independent survey, approximately 80% of pharmaceutical companies are planning to invest in continuous manufacturing in 2010. MRT offers exclusive results that cannot be achieved via any other method. However, it requires more than a machine. Particle Sciences was chosen as an early site for the technology because of their deep knowledge around both pharmaceutical formulation and nanoparticle engineering. We are confident that their experienced engineers are fully trained and capable of developing processes for customers which will meet their precise and most demanding requirements."

Continuous crystallization via MRT was introduced to the United States at INTERPHEX 2010 in New York City on April 21, 2010. For more information contact Particle Sciences at (610) 861-4701. Microfluidics' webinar on MRT can be viewed at and clicking on the MRT webinar link.

About Microfluidics

Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. The equipment enables the formulation and manufacture of numerous nanomaterials and nanoscale products and produces the most uniform and smallest liquid and suspended solid particles available. Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the biotechnology, pharmaceutical, chemical and cosmetics industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market. Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at any of three Microfluidics facilities. Visit, email or contact Microfluidics at (800) 370-5452 for application information

About Particle Sciences

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit, email or contact us at (610) 861-4701 for information.

Contact: Maureen Cochran


SOURCE Particle Sciences

Back to news